Nanomedicine has emerged as an interdisciplinary field that uses nanotechnology to diagnose, treat and monitor diseases like cancer. The paper reviews recent advances in using nanoparticles, liposomes, dendrimers and carbon-based nanomaterials to enhance targeted drug delivery for cancer therapy and reduce side effects. It also discusses how contrast agents and nanosensors can improve cancer imaging for early detection, accurate staging of cancer and monitoring treatment response, enabling personalized medicine approaches and better patient outcomes.
Nanomedicine has emerged as an interdisciplinary field that uses nanotechnology to diagnose, treat and monitor diseases like cancer. The paper reviews recent advances in using nanoparticles, liposomes, dendrimers and carbon-based nanomaterials to enhance targeted drug delivery for cancer therapy and reduce side effects. It also discusses how contrast agents and nanosensors can improve cancer imaging for early detection, accurate staging of cancer and monitoring treatment response, enabling personalized medicine approaches and better patient outcomes.
Nanomedicine has emerged as an interdisciplinary field that uses nanotechnology to diagnose, treat and monitor diseases like cancer. The paper reviews recent advances in using nanoparticles, liposomes, dendrimers and carbon-based nanomaterials to enhance targeted drug delivery for cancer therapy and reduce side effects. It also discusses how contrast agents and nanosensors can improve cancer imaging for early detection, accurate staging of cancer and monitoring treatment response, enabling personalized medicine approaches and better patient outcomes.
Abstract: Nanomedicine has emerged as a cutting-edge field at the intersection of nanotechnology and medicine, presenting tremendous potential in the diagnosis, treatment, and monitoring of various diseases, especially cancer. This paper presents a comprehensive review of the recent advancements and applications of nanomedicine in cancer therapeutics. We begin by providing an overview of the unique properties of nanomaterials that make them ideal candidates for targeted drug delivery, imaging, and therapy in cancer. Nanoparticles, liposomes, dendrimers, and carbon-based nanomaterials are among the key platforms used to enhance drug efficacy and reduce off-target effects. The paper then delves into the multifunctional role of nanomedicine in cancer imaging, discussing the use of contrast agents and nanosensors for early detection, precise staging, and real-time monitoring of treatment response. These imaging techniques enable personalized medicine approaches, leading to better patient outcomes.